BioAdaptives, Inc. (BDPT)
OTCMKTS · Delayed Price · Currency is USD
0.0013
0.00 (0.00%)
Sep 10, 2026, 10:12 AM EST
BioAdaptives Revenue
BioAdaptives had revenue of $4.99K in the quarter ending June 30, 2026, with 54.95% growth. This brings the company's revenue in the last twelve months to $25.56K, up 694.07% year-over-year. In the year 2025, BioAdaptives had annual revenue of $18.28K with 44.27% growth.
Revenue (ttm)
25.56K
Revenue Growth
+694.07%
P/S Ratio
10.02
Revenue / Employee
25.56K
Employees
1
Market Cap
256.01K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 18.28K | 5.61K | 44.27% |
| Dec 31, 2024 | 12.67K | -15.90K | -55.65% |
| Dec 31, 2023 | 28.57K | 11.39K | 66.31% |
| Dec 31, 2022 | 17.18K | -2.60K | -13.15% |
| Dec 31, 2021 | 19.78K | 3.45K | 21.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| The Real Good Food Company | 156.38M |
| Ayujoy Herbals | 70.87M |
| Amincor | 23.56M |
| Oriental Rise Holdings | 12.22M |
| Twinlab Consolidated Holdings | 11.67M |
| Functional Brands | 6.70M |
| Blue Star Foods | 1.54M |
| Energy Today | 846.81K |
BioAdaptives News
- 7 days ago - BioAdaptives Confirms First Commercial Orders of XcellaraHeart(TM) and Outlines Capital Restructuring Progress - Accesswire
- 10 days ago - UFC Hall of Famer Michael Bisping Joins BioAdaptives to Champion MyndSystem(TM) - Accesswire
- 4 weeks ago - BioAdaptives, Inc. Announces CEO's Share Cancellation and Provides Capital Restructure Update - Accesswire
- 4 weeks ago - BioAdaptives Inc. Introduces XcellaraHeart(TM): the World's First Stem Cell Mobilizer with a Targeted Cardiac Homing Signal - Accesswire
- 5 weeks ago - BioAdaptives Inc. Opens Commercial Ordering Window for XcellaraHeart(TM) Cellular Wellness Formula - Accesswire
- 6 weeks ago - BioAdaptives Inc. Eliminates Major Market Overhang by Retiring the Debt of the Largest Convertible Commercial Investor - Accesswire
- 6 weeks ago - BioAdaptives Inc. Reports Scaling of E-Commerce Footprint and Consumer Reach for MyndSystem(TM) Nootropic Platform - Accesswire
- 7 weeks ago - BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches - GlobeNewsWire